Literature DB >> 27423084

Effects of exercise-based cardiac rehabilitation on cardiorespiratory fitness: A meta-analysis of UK studies.

Meshal Almodhy1, Lee Ingle2, Gavin R Sandercock3.   

Abstract

BACKGROUND: Exercise-based cardiac rehabilitation can promote meaningful improvements in cardiorespiratory fitness (fitness) but the magnitude of such improvements varies according to local characteristics of exercise programmes. We aimed to determine if cardiac rehabilitation (CR), as practised in the United Kingdom (UK), could promote meaningful changes in fitness and to identify programme characteristics which may moderate these changes.
METHODS: Electronic and manual searches to identify UK CR studies reporting fitness at baseline and follow up. Change in fitnessfitness) was expressed as mean difference (95% CI) and effect size (ES). A random effects model was used to calculate the mean estimate for change in Δfitness. Between-group heterogeneity was quantified (Q) and investigated using planned sub-group analyses.
RESULTS: We identified n=11 studies containing 16 patient groups (n=1 578) which used the incremental shuttle walking test (ISWT) (distance walked) to assess fitness. The overall mean estimate for Δfitness showed a significant increase in distance walked (ES=0.48, P<0.001), but this estimate was highly heterogeneous (Q=77.1, P<0.001, I(2)=81%). Sub-group analyses showed significantly greater ES (Q=3.94, P=0.046) for Δfitness in patients prescribed n>12 exercise sessions compared with those receiving n≤12 sessions.
CONCLUSION: We found significant increases in fitness (based on ISWT) in patients attending exercise-based CR in the UK. However, UK studies provide approximately one-third of the exercise "dose", and produce gains in fitness less than half the magnitude reported in international studies.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aerobic capacity; Exercise prescription; Subgroup analysis; Systematic review

Mesh:

Year:  2016        PMID: 27423084     DOI: 10.1016/j.ijcard.2016.06.101

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Cardiac Rehabilitation for Secondary Prevention of Cardiovascular Disease: 2019 Update.

Authors:  Randal J Thomas; Hsu-Hang Huang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-05

Review 2.  Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity.

Authors:  Jenna L Taylor; Amanda R Bonikowske; Thomas P Olson
Journal:  Front Cardiovasc Med       Date:  2021-09-03

3.  Exercise dose and all-cause mortality within extended cardiac rehabilitation: a cohort study.

Authors:  Claire Taylor; Costas Tsakirides; James Moxon; James W Moxon; Michael Dudfield; Klaus Witte; Lee Ingle; Sean Carroll
Journal:  Open Heart       Date:  2017-07-28

4.  Is the Comparison between Exercise and Pharmacologic Treatment of Depression in the Clinical Practice Guideline of the American College of Physicians Evidence-Based?

Authors:  Yael Netz
Journal:  Front Pharmacol       Date:  2017-05-15       Impact factor: 5.810

5.  Insufficient exercise intensity for clinical benefit? Monitoring and quantification of a community-based Phase III cardiac rehabilitation programme: A United Kingdom perspective.

Authors:  Alaa Khushhal; Simon Nichols; Sean Carroll; Grant Abt; Lee Ingle
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

6.  Association of Neighborhood Socioeconomic Context With Participation in Cardiac Rehabilitation.

Authors:  Justin M Bachmann; Shi Huang; Deepak K Gupta; Loren Lipworth; Michael T Mumma; William J Blot; Elvis A Akwo; Sunil Kripalani; Mary A Whooley; Thomas J Wang; Matthew S Freiberg
Journal:  J Am Heart Assoc       Date:  2017-10-11       Impact factor: 5.501

7.  Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-II).

Authors:  Annett Salzwedel; Katrin Jensen; Bernhard Rauch; Patrick Doherty; Maria-Inti Metzendorf; Matthes Hackbusch; Heinz Völler; Jean-Paul Schmid; Constantinos H Davos
Journal:  Eur J Prev Cardiol       Date:  2020-02-23       Impact factor: 7.804

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.